Currently, several performance evaluations of SARS-CoV-2 IVDs are being implemented byregulatory authorities, reference laboratories and other stakeholders in various regions.Manufacturer are strongly encouraged to participate in initiatives which generate evidence that canbe used to support the EUL submission, However, participation in external evaluations does notreplace the EUL submission nor is participation in such studies mandatory for submission to theWHO EUL.
